SGLT2 Inhibitors in Geographic Atrophy

NCT07174687 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Retinal Degeneration
Retinal Diseases
Eye Diseases
Geographic Atrophy
Pathological Conditions, Anatomical

Interventions

DRUG: Dapagliflozin
OTHER: Matching Placebo

Sponsor

Washington University School of Medicine